Literature DB >> 29596030

Potential Value of YAP Staining in Rhabdomyosarcoma.

Atif A Ahmed1, Sultan S Habeebu1, Ashley K Sherman2, Shui Q Ye3,4, Nicole Wood5, Katherine M Chastain5, Maria G Tsokos6.   

Abstract

Rhabdomyosarcoma (RMS) is a common malignancy of soft tissue, subclassified as alveolar (ARMS), pleomorphic (PRMS), spindle cell/sclerosing (SRMS), and embryonal (ERMS) types. The Yes-associated protein (YAP) is a member of the Hippo pathway and a transcriptional regulator that controls cell proliferation. We have studied the immunohistochemical expression of YAP in different RMSs, arranged in tissue microarray (TMA) and whole slide formats. Pertinent clinical data including patient age, gender, tumor location, and clinical stage were collected. Out of 96 TMA cases, 30 cases (31%) were pleomorphic, 27 (28%) were embryonal, 24 (25%) alveolar, and 15 (16%) spindle cell. Positive nuclear YAP staining was seen in the PRMS (17/30, 56.7%), SRMS (7/15, 46.7%), ERMS (19/27 or 70%), and less in ARMS (37.5%). YAP nuclear staining was significantly more prevalent in ERMS than ARMS ( p=0.02). Of the 41 whole slide cases, nuclear staining was detected in all ARMS but was restricted in distribution to <30% of the cells, in contrast to ERMS and SRMS, which had diffuse or >30% staining. These results highlight the role of YAP in RMS tumorigenesis, a fact that can be useful in engineering targeted therapy. Restricted nuclear YAP staining (<30% of cells) may be of value in the diagnosis of ARMS.

Entities:  

Keywords:  Hippo; IHC; YAP; rhabdomyosarcoma; tissue microarray

Mesh:

Substances:

Year:  2018        PMID: 29596030      PMCID: PMC6071181          DOI: 10.1369/0022155418766515

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  19 in total

Review 1.  The Hippo Pathway: A Master Regulatory Network Important in Development and Dysregulated in Disease.

Authors:  Cathie M Pfleger
Journal:  Curr Top Dev Biol       Date:  2017-01-19       Impact factor: 4.897

2.  The Role of Immunohistochemistry in Rhabdomyosarcoma Diagnosis Using Tissue Microarray Technology and a Xenograft Model.

Authors:  Isidro Machado; Empar Mayordomo-Aranda; Francisco Giner; Antonio Llombart-Bosch
Journal:  Fetal Pediatr Pathol       Date:  2015-06-30       Impact factor: 0.958

3.  Elevated YAP and its downstream targets CCN1 and CCN2 in basal cell carcinoma: impact on keratinocyte proliferation and stromal cell activation.

Authors:  Taihao Quan; Yiru Xu; Zhaoping Qin; Patrick Robichaud; Stephanie Betcher; Ken Calderone; Tianyuan He; Timothy M Johnson; John J Voorhees; Gary J Fisher
Journal:  Am J Pathol       Date:  2014-01-30       Impact factor: 4.307

4.  Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.

Authors:  S Kumar; E Perlman; C A Harris; M Raffeld; M Tsokos
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

5.  An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience.

Authors:  Raffaella A Morotti; Kathleen K Nicol; David M Parham; Lisa A Teot; Julie Moore; John Hayes; William Meyer; Stephen J Qualman
Journal:  Am J Surg Pathol       Date:  2006-08       Impact factor: 6.394

Review 6.  Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.

Authors:  F G Barr
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

7.  Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.

Authors:  Juan Miguel Mosquera; Andrea Sboner; Lei Zhang; Naoki Kitabayashi; Chun-Liang Chen; Yun Shao Sung; Leonard H Wexler; Michael P LaQuaglia; Morris Edelman; Chandrika Sreekantaiah; Mark A Rubin; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2013-03-05       Impact factor: 5.006

Review 8.  The Hippo signal transduction pathway in soft tissue sarcomas.

Authors:  Abdalla D Mohamed; Annie M Tremblay; Graeme I Murray; Henning Wackerhage
Journal:  Biochim Biophys Acta       Date:  2015-06-04

9.  Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma.

Authors:  Katherine K Slemmons; Lisa E S Crose; Erin Rudzinski; Rex C Bentley; Corinne M Linardic
Journal:  PLoS One       Date:  2015-10-23       Impact factor: 3.240

10.  TAZ and YAP are frequently activated oncoproteins in sarcomas.

Authors:  Colleen A Fullenkamp; Sarah L Hall; Omar I Jaber; Brittany L Pakalniskis; Erica C Savage; Johanna M Savage; Georgina K Ofori-Amanfo; Allyn M Lambertz; Stephanie D Ivins; Christopher S Stipp; Benjamin J Miller; Mohammed M Milhem; Munir R Tanas
Journal:  Oncotarget       Date:  2016-05-24
View more
  1 in total

1.  Establishment and Characterization of a Cell Line (S-RMS1) Derived from an Infantile Spindle Cell Rhabdomyosarcoma with SRF-NCOA2 Fusion Transcript.

Authors:  Marta Colletti; Angela Galardi; Evelina Miele; Virginia Di Paolo; Ida Russo; Cristiano De Stefanis; Rita De Vito; Martina Rinelli; Andrea Ciolfi; Biagio De Angelis; Angelica Zin; Alessandro Guffanti; Maria Cristina Digilio; Antonio Novelli; Rita Alaggio; Giuseppe Maria Milano; Angela Di Giannatale
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.